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RNA silencing is a major antiviral defense mechanism in plants and
invertebrates. Plant ARGONAUTE1 (AGO1) is pivotal in RNA silenc-
ing, and hence is a major target for counteracting viral suppressors
of RNA-silencing proteins (VSRs). P0 from Turnip yellows virus
(TuYV) is a VSR that was previously shown to trigger AGO1 deg-
radation via an autophagy-like process. However, the identity of
host proteins involved and the cellular site at which AGO1 and P0
interact were unknown. Here we report that P0 and AGO1 asso-
ciate on the endoplasmic reticulum (ER), resulting in their loading
into ER-associated vesicles that are mobilized to the vacuole in an
ATG5- and ATG7-dependent manner. We further identified ATG8-
Interacting proteins 1 and 2 (ATI1 and ATI2) as proteins that asso-
ciate with P0 and interact with AGO1 on the ER up to the vacuole.
Notably, ATI1 and ATI2 belong to an endogenous degradation
pathway of ER-associated AGO1 that is significantly induced fol-
lowing P0 expression. Accordingly, ATI1 and ATI2 deficiency causes
a significant increase in posttranscriptional gene silencing (PTGS)
activity. Collectively, we identify ATI1 and ATI2 as components of
an ER-associated AGO1 turnover and proper PTGS maintenance and
further show how the VSR P0 manipulates this pathway.
RNA silencing | autophagy | Arabidopsis
In eukaryotes, gene silencing is essential for development andplays important roles in response to biotic and abiotic stresses,
as well as in epigenetic control of transposable elements. RNA
silencing involves the processing of double-stranded (ds)RNA by
Dicer-like RNase III enzymes, into small RNAs (sRNAs) of 21
to 24 nucleotides in length (1). All types of sRNAs are then
incorporated into a protein complex called RISC (RNA-induced
silencing complex) that invariably contains a member of the
highly conserved Argonaute (AGO) protein family (2, 3). These
RISCs are programmed by the bound sRNAs to specifically in-
teract with transcripts based on sequence complementarity,
resulting in messenger RNA (mRNA) cleavage, translational re-
pression, or chromatin modification. An important class of en-
dogenous sRNAs is microRNAs (miRNAs) (4, 5), which repress
the expression of one or more target mRNAs and have been
predicted to control a significant proportion of the transcriptome
(6). Important functions for sRNAs have also emerged in the
study of host−pathogen interactions. In particular, RNA silencing
plays a key role in antiviral defense in plants and invertebrates,
where populations of sRNAs are produced in infected cells di-
rectly by processing dsRNA molecules derived from the viral ge-
nome (7, 8). These virus-derived small interfering RNAs (siRNAs)
are then incorporated into an antiviral RISC and turned back onto
viral RNAs to trigger their degradation.
In the model plant Arabidopsis thaliana (hereafter referred to
as Arabidopsis), the AGO protein family is composed of 10 members
divided into 3 major clades based on their protein similarity (9).
Among them, AGO1 plays a central role in both miRNA- and
siRNA-directed silencing (10). Hence, AGO1 loaded with sRNAs
mediates endonucleolytic cleavage of target transcripts (11), but a
fraction of transcripts also evades slicing and instead undergoes
translation repression (12, 13). Moreover, AGO1 plays an im-
portant function in the biogenesis and control of secondary
siRNAs (14–16). Finally, besides its regulatory role of endogenous
gene expression through miRNAs and endogenous siRNAs, AGO1
is paramount in antiviral defense, and, consequently, various ago1
mutants exhibit enhanced susceptibility to virus infection (17, 18).
However, as a counter defense strategy, viruses have acquired
various viral suppressors of RNA silencing (VSRs), which can
target different steps of the RNA silencing pathway (19, 20).
Previous work from our laboratory and others revealed that
the VSR protein P0 from Polerovirus encodes an F-box protein
that hijacks the host S-phase kinase-associated protein1 (SKP1)-
cullin 1 (CUL1)-F-box protein (SCF) ubiquitin-protein ligase
(E3) to promote AGO1 degradation (21–24). Although different
Significance
The viral suppressor of RNA silencing P0 is known to target
plant antiviral ARGONAUTE (AGO) proteins for degradation via
an autophagy-related process. Here we utilized P0 to gain in-
sight into the cellular degradation dynamics of AGO1, the major
plant effector of RNA silencing. We revealed that P0 targets
endoplasmic reticulum (ER)-associated AGO1 by inducing the
formation of ER-related bodies that are delivered to the vacuole
with both P0 and AGO1 as cargos. This process involves ATG8-
interacting proteins 1 and 2 (ATI1 and ATI2) that interact with
AGO1 and negatively regulate its transgene-silencing activity.
Together, our results reveal a layer of ER-bound AGO1 post-
translational regulation that is manipulated by P0 to subvert
plant antiviral defense.
Author contributions: S.M., M.C., C.V., and P.G. designed research; S.M., M.C., E.L., C.V.,
J.W., M.D., T.H., B.D., E.I., M.L., N.B., and H.V. performed research; J.W., J.D.C., V.Z.-G., and
G.G. contributed new reagents/analytic tools; S.M., M.C., E.L., C.V., M.D., T.H., B.D., E.I.,
M.L., V.Z.-G., H.V., and P.G. analyzed data; and P.G. wrote the paper with the
participation of S.M.
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
1To whom correspondence may be addressed. Email: pascal.genschik@ibmp-cnrs.
unistra.fr.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1912222116/-/DCSupplemental.
First published October 18, 2019.






















Poleroviruses encode P0 proteins that lack sequence similarity,
most of them can mediate the decay of AGOs (25, 26). SCF-type
ubiquitin E3 ligases promote ubiquitylation of their substrates,
which serves as a signal for proteasomal degradation (27, 28).
However, inhibition of the proteasome was unable to block P0-
mediated degradation of AGO1 (22). Instead, it was shown that
AGO1 degradation was blocked by pharmacological inhibition of
trafficking pathways that lead to the vacuole, including macro-
autophagy, and that P0 expression leads to an accumulation of
AGO1 in vacuolar inclusions (29).
Macroautophagy (hereafter referred to as autophagy) is an
evolutionary conserved intracellular degradation and recycling
mechanism involving the generation of a specialized double
membrane termed the phagophore, which likely emanates from
the endoplasmic reticulum (ER) (30, 31). The phagophore cap-
tures cytosolic content (cargo) and then seals to form an auto-
phagosome that delivers the cargo to cellular lytic compartments
(lysosomes in animals or vacuoles in yeast and plants). The
autophagy process requires more than 40 proteins to function,
most of which are annotated as autophagy-related proteins (ATG)
(32–34). Under energetically demanding stress, cells induce non-
selective autophagy, by which cytosolic content is degraded.
However, under specific stress and developmental conditions,
subcellular structures are cleared by selective autophagy (34–36), a
process implying specialized cargo receptors that anchor the
cargo to autophagy machinery components. In many cases, cargo
receptors interact with ATG8 proteins, which are known to dec-
orate both the inner and outer membranes of the autophagosome
and are involved in autophagosome maturation as well as in their
fusion with the lytic compartment. Frequently, ubiquitylation
serves as a signal for the recognition of cargoes destined for se-
lective autophagy (36). In plants, only a few selective autophagy
receptors have been identified (34). Among them are neighbor of
BRCA 1 (NBR1), a functional hybrid of mammalian p62 and
NBR1 autophagy receptors, which targets ubiquitylated protein
aggregates in plant stress responses (37, 38) and virus particles
(39), tryptophan-rich sensory protein (TSPO) that can target
plasma-membrane based aquaporins (40), and RPN10, which
degrades inactive 26S proteasomes (41). ATG8-interacting 1 and 2
(ATI1 and ATI2), on the other hand, are transmembrane proteins
reported to localize to ER- and plastid-derived vesicles that traffic
to the vacuole (42, 43). Although ATI1/2 interact with ATG8f and
rely on core autophagy machinery to reach the vacuole, ATI1/2
decorated bodies are generally distinct from ATG8-decorated
autophagosomes, and their function on the ER is still poorly
understood (42).
The pivotal role of autophagy during viral infection in plants
has only recently emerged, with reports demonstrating both anti-
viral and proviral functions (44, 45). At present, little is known
about the mechanism of P0-mediated AGO1 protein degradation.
The viral F-box protein P0 has been proposed to act upstream of
AGO1 loading (24), as it is very effective in degrading newly
synthesized AGO1 after transient expression in tobacco leaves, but
not endogenous preassembled AGO1 complex. We recently found
that P0 recognizes the DUF1785 domain of AGO1 to enable its
degradation (46), but where this occurs at the subcellular level is
unknown. Notably, AGO1 protein also decays via a similar path-
way in a P0-independent manner, when miRNA production or
stability is compromised (29). However, the assumption that the
AGO1 protein decays via autophagy in a P0-dependent and in-
dependent context mainly relies on the use of pharmacological
treatments known to inhibit autophagy, and whether this mecha-
nism involves a cargo receptor is presently unknown.
Here we took advantage of the VSR P0 of Turnip yellows virus
(TuYV) to induce and monitor Arabidopsis AGO1 degradation
dynamics. We report that the ERmembrane is the main site where
AGO1 and P0 encounter each other, forming ER-associated
bodies that contain both proteins and are delivered to the
vacuole. These bodies require functional autophagy to reach the
vacuole, yet autophagy deficiency is unable to block P0-mediated
AGO1 degradation. We further identified the ER-localized
proteins ATI1/2 (42, 43) as proteins that mediate the delivery
of both AGO1 and P0 as cargoes en route to the vacuole. ATI1
directly interacts with AGO1, and P0 expression is sufficient to
induce a flux of ATI1-decorated vesicles to the vacuole. Defi-
ciency in both ATI1/2 does not lead to a marked increase of
AGO1 protein steady-state levels, yet attenuates membrane-
associated AGO1 degradation following P0 induction and re-
sults in significantly increased sense transgene-mediated post-
transcriptional gene silencing (S-PTGS) activity. Together, our
results suggest that ER-bound AGO1 is targeted for vacuolar
degradation and that the VSR P0 evolved to manipulate this
pathway.
Results
P0 Encounters AGO1 on the ER and Both Proteins Are Codelivered to
the Vacuole. Previous reports indicated that AGO1 appears in
membrane-bound and membrane-free (soluble) forms (13, 47),
and that miRNAs copurify with membrane-bound polysomes
through their association with AGO1 (48). To learn more about
P0-mediated AGO1 degradation, we first examined whether ei-
ther of the 2 AGO1 pools is more prone to degradation than the
other. To this end, we used the XVE:P0-myc line (29), in which
P0-myc expression is under the control of a β-Estradiol (β-Es)−
inducible promoter. We treated XVE:P0-myc seedlings with ei-
ther dimethyl sulfoxide (DMSO) as mock (−) or β-Es (+) and
evaluated AGO1 protein level in soluble and microsomal frac-
tions (Fig. 1A). The marker for ER lumen (BiP) was enriched in
the microsomal fraction, whereas the cytosolic enzyme UDP-
glucose pyrophosphorylase (UGPase) was almost absent, yet
enriched in the soluble fraction. Most AGO1 protein was de-
tected in microsomes, and its abundance decreased after β-Es
treatment. Although P0-myc was also present in the soluble
fraction, the P0-myc detected in the microsomes is likely the
cause of membrane-bound AGO1 decay (Fig. 1A). Additionally,
the presence of P0-myc in the soluble fraction enables the deg-
radation of the soluble pool of AGO1 and AGO4, the latter
being enriched in the soluble fraction as previously reported
(48). Since miRNA localization to membranes arises from their
association with AGO1, membrane-associated AGO1 degrada-
tion by P0-myc should lead to a decrease in miRNA in the mi-
crosomal fraction. Indeed, while the levels of some inspected
miRNAs (miR173, miR167, and miR159) were largely unaf-
fected in the soluble fraction, their abundance was markedly
decreased in the presence of P0-myc in microsomes, while 24-nt
siR1003 that associates with AGO4 was only detected in the
soluble fraction (SI Appendix, Fig. S1). From these results, we
conclude that the viral F-box P0 exerts its activity on both soluble
and membrane-bound AGO1, and that P0-mediated degradation
of membrane-associated AGO1 results in decreased miRNA-
programmed RISC in membranes (SI Appendix, Fig. S1).
To determine the identity of the intracellular membranes with
which P0 may associate, its coding sequence was fused to either
GFP (P0-GFP) or mRFP (P0-mRFP) under the control of the
constitutive Cauliflower Mosaic Virus 35S promoter. Addition-
ally, P0-mRFP was also expressed under the control of the β-Es−
inducible promoter (XVE:P0-mRFP). Transient expression as-
says in Nicotiana benthamiana revealed that both P0-GFP and
P0-mRFP are as efficient as the previously reported P0-myc in
degrading AGO1 and that mutating the P0-mRFP F-box domain
(XVE:P0LP-mRFP) fully abolished AGO1 degradation (SI Ap-
pendix, Fig. S2A). Expression of P0-GFP along with the ER
marker mCherry-HDEL in N. benthamiana leaf cells revealed
that the viral F-box protein partially overlaps with the ER and
labels ER-associated bodies (SI Appendix, Fig. S2B and Movie
S1). Next, we generated XVE:P0-mRFP Arabidopsis stable lines































that exhibit efficient P0-mRFP induction following treatment
with β-Es (SI Appendix, Fig. S2C). Staining root cells that express
P0-mRFP with ER-Tracker (Thermo Fisher Scientific) demon-
strated again its partial association with the ER (Fig. 1B). How-
ever, in this system, a broader distribution of the signal along the
ER was observed with the addition of bodies that appear associ-
ated with the ER-Tracker signal. These observations suggest that
the ER might be a site from which membrane-bound AGO1 is
targeted for degradation.
Previously, it was reported that AGO1 localizes on the ER
membrane (13, 48). We reexamined this by utilizing both fluorescence
and electron microscopy (EM) techniques. First, we transiently
expressed 35S:GFP-AGO1 in N. benthamiana epidermal leaf
cells along with the ER marker mCherry-HDEL and focused
on the cytosolic focal planes. This revealed partial association
of AGO1 with the ER in 52% of the examined cells (n = 32) (SI
Appendix, Fig. S3 A, Top), while, in other transformed cells, the
signal was cytosolic (SI Appendix, Fig. S3 A, Bottom). To gain insight
into the localization of the endogenous AGO1 and the impact
of P0 expression on AGO1 localization at the ultrastructural
level, we treated Col-0 and XVE:P0-mRFP seedlings with β-Es
and concanamycin A (ConcA; an inhibitor of vacuolar degradation),
Fig. 1. P0 and AGO1 colocalize in ER-associated bodies that are destined to the vacuole. (A) Immunoblot analysis of total, pellet (Microsomal), and su-
pernatant (Soluble) protein preparations from XVE:P0-myc 7-d-old seedlings grown on Murashige and Skoog (MS) plates with either DMSO (−) or 10 μM β-Es
(+). Blots were probed with antibodies raised against Arabidopsis AGO1, AGO4, the c-MYC tag, Luminal binding proteins BiP1/BiP2/BiP3 (BiP), and UGPase.
Coomassie blue (CB) staining serves as loading control. (B) CLSM imaging of Arabidopsis root meristematic cells expressing P0-mRFP (red signal) and stained
with ER-Tracker blue-white DPX (ThermoFisher; green signal). Both the merged image of the signals and an enlarged image of one of the cells are presented.
Positions of the nucleus (N) and P0-mRFP labeled bodies (arrowheads) are indicated. (C) (Top andMiddle) TEM imaging of ER (denoted by a dashed red line) in a
root cell that underwent immunogold labeling using @AGO1 antibodies. Arrowheads mark the sites of gold particles in Top. Both Col-0 and the XVE:P0-mRFP
line were treated with β-Es and ConcA. (Scale bars: 200 nm.) (Bottom) A graph showing quantification of gold particles associated with the ER, tonoplast (vac.),
endosomes (end.), plasma membrane (PM), and plastid + mitochondria (pl./mit.) outer membranes. Quantification was done in samples from β-Es and ConcA
treated (+B+C), or untreated, Col-0 plants. Values represent mean ± SEM. Asterisk (*) denotes statistical significance of gold particle numbers along the ER
compared to the other membranes within the +B+C treated plants, P < 0.05 (Mann–Whitney U test). (D) (Top) CLSM imaging of a tobacco leaf epidermal cell
transiently expressing GFP-AGO1 (AGO1), CFP-HDEL (ER), and P0-mRFP (P0). (Bottom) Enlargements of the areas bordered by yellow rectangles in Top. Bodies
exhibiting both P0 and AGO1 signals are highlighted with arrowheads. (E) Immunoblot analysis of total proteins from XVE:P0-mRFP seedlings treated with β-Es
for 0, 8, 24, and 48 h to induce P0-mRFP expression. Blots were probed with specific antibodies as indicated, and CB staining serves as loading control. (F) CLSM
imaging of the vacuolar focal plane of root elongation zone cells from an Arabidopsis line harboring pAGO1:GFP-AGO1 and XVE:P0-mRFP and treated with β-Es
and ConcA or mock (DMSO) and ConcA. Vacuole lumen is indicated (Vac).






















and analyzed root cells by immuno-EM (IEM) with the anti-AGO1
antibody. We reasoned that using Col-0 plants that were subjected
to the same chemicals as XVE:P0-mRFP plants would allow the
assessment of the effect of P0 per se, excluding the possible in-
fluence of the drugs. In Col-0 seedlings, the compartment showing
the highest AGO1 labeling density on its limiting membrane was
the ER (Fig. 1 C, Top and Bottom). In P0-mRFP seedlings, AGO1
labeling was detected in few cases on electron-dense structures
adjacent to the ER membrane (Fig. 1 C, Middle and SI Appendix,
Fig. S4). Such structures were not detected in the Col-0 samples.
This suggests that P0 expression may result in the aggregation of
AGO1 in ER-associated structures. Quantification revealed that
most of the gold particles were present along the ER compared to
all other membranes in both treated and untreated Col-0. How-
ever, this enrichment was only statistically significant in the
chemically treated seedlings (Mann−Whitney U test, P < 0.05)
(Fig. 1 C, Bottom). This might be due to the inhibitory impact
of ConcA on vacuolar degradation, resulting in more protein
lingering on the ER membrane. Hence, although AGO1 may
associate with several membranes and appear also in a soluble
form, our results corroborate previous reports pointing toward
the ER as a major site for membrane-bound AGO1 (13, 48). Notably,
P0 expression affects the morphology of ER-associated AGO1. In
support of this, coexpression of GFP-AGO1 and P0-mRFP in N.
benthamiana leaves revealed that both proteins exhibited an ER-
like expression pattern and colocalized in bodies (SI Appendix, Fig.
S3B). To see whether these structures are indeed associated with
the ER, we expressed GFP-AGO1 and P0-mRFP along with an
ER marker, CFP-HDEL (Fig. 1D). Structures containing P0-
mRFP were indeed closely associated with the ER, and some
were also enriched with the GFP-AGO1 signal (Fig. 1D, white
arrowheads). Moreover, time-lapse imaging revealed the motile
nature of the P0 and AGO1 labeled bodies (Movie S2). Note that
the colocalization of GFP-AGO1 and P0-mRFP was only detected
at early time points of their expression, that is, 24 h to 40 h fol-
lowing agroinfiltration (hfa). At later time points, that is, 48 hfa to
96 hfa, AGO1-labeled foci were no longer detected, probably due
to AGO1 degradation. Moreover, in these transient expression assays,
GFP-AGO1 and P0-mRFP were also occasionally detected in
the nuclei (SI Appendix, Fig. S3C).
Next, we took advantage of the relative stability of mRFP
to examine whether P0-mRFP is delivered to vacuoles. Total
protein extraction from XVE:P0-mRFP seedlings at 0, 8, 24,
and 48 h following P0-mRFP induction revealed that AGO1
protein level decreases as the free-mRFP vacuolar degradation
product of P0-mRFP accumulates (Fig. 1E), suggesting that P0-
mRFP might be delivered to the vacuole along with its tar-
get AGO1. To address this, the pAGO1:GFP-AGO1/ago1-27
transgenic line (29) was transformed with XVE:P0-mRFP, and
lines harboring both constructs were analyzed. Imaging of root
cells in the elongation zone following β-Es and ConcA treatment,
compared to ConcA-only treated plants, revealed accumulation
of P0-mRFP− and GFP-AGO1−containing bodies within the
vacuoles (Fig. 1F). Time-lapse imaging demonstrated random
motion of the bodies, which is typical for vacuole-lumen-residing
autophagic bodies (Movie S3). Together, these observations point
toward the ER as a major site from which P0 induces AGO1
degradation and from which it is delivered to the vacuole along
with AGO1.
Autophagy Deficiency Impairs P0 Delivery to the Vacuole, yet Is
Unable to Block AGO1 Degradation. Next, we examined whether
P0 associates with autophagy components and whether it relies
on autophagy for its function. We previously showed that
GFP-AGO1 colocalizes with an autophagosome marker, mRFP-
ATG8a, especially following P0 expression or treatment with the
membrane-permeable cysteine protease inhibitor E64d in N.
benthamiana leaves (29). To determine whether P0 also colocalizes
with autophagosomes, we coexpressed P0-GFP and mRFP-
ATG8a in N. benthamiana leaves and imaged them at 40 hfa. As
expected, the mRFP-ATG8a protein was detected in the cytosol and
the nucleus, as well as in small bodies representing autophagosomes
(Fig. 2A). Notably, P0-GFP predominantly colocalized with
mRFP-ATG8a in these bodies. To determine whether the deg-
radation of P0 bodies is regulated by autophagy, we introduced
XVE:P0-mRFP or XVE:P0-myc into atg5-1 and atg7-2, in which
autophagy is inactive (49). First, we utilized XVE:P0-mRFP/
atg5-1 and XVE:P0-mRFP/atg7-2 lines and examined their
vacuoles following 18- to 24-h P0-mRFP induction (β-Es) and
treatment with ConcA. While P0-mRFP bodies accumulated
in the vacuoles of control plants (XVE:P0-mRFP; on average
exhibited 59 bodies per 1,000 μm2 of vacuole lumen focal plane),
there were almost no bodies detected in XVE:P0-mRFP/atg5-1
(1 body per 1,000 μm2) and significantly less P0-mRFP bodies
(3.6 bodies per 1,000 μm2) within the vacuoles of XVE:P0-mRFP/
atg7-2 (Fig. 2 B and C). Moreover, in cells of the meristematic
zone, both autophagy mutants displayed cytosolic structures of
about 4 μm in diameter that contain P0-mRFP and that were
absent from wild-type cells (Fig. 2B). These structures were
motile (Movie S4) and may represent aggregated P0-mRFP that
accumulates due to degradation blockage.
Given this observation and the fact that the application of
vacuolar-degradation inhibitors such as E64d is sufficient to
counteract the degradative effect of P0-myc on AGO1 (29), we
speculated that genetic disruption of autophagy might achieve
similar results. To test this, we utilized our XVE:P0-myc/atg5-1
and XVE:P0-myc/atg7-2 lines and expressed P0-myc in 2 ways: 1)
by germinating the plants on β-Es containing media (constitutive
P0 expression) compared to mock (DMSO containing media) or
2) by treating seedlings with β-Es or mock 5 d after their ger-
mination (induced P0 expression). Strikingly, following P0 ex-
pression in both assays (Fig. 2D and SI Appendix, Fig. S5 A and
B), none of the autophagy mutant was able to block either AGO1
or AGO2 degradation. On the contrary, the AGO1 transcript level
was significantly increased, ruling out the possibility that the de-
cline of protein level is due to reduced transcript level (Fig. 2D).
Note that AGO1, but not AGO2, protein level remained stable in
the ago1-57 allele background, used here as a control. This line is
insensitive to P0, as this mutation abrogates the SCF-dependent
P0 interaction with AGO1 (46).
We next wondered whether the 26S proteasome could take over
P0-mediated AGO1 protein decay if autophagy is compromised.
However, when applying Bortezomib, which binds and blocks with
high affinity and specificity the 26S proteasome (50), AGO1 was
still degraded by P0 in atg5-1 mutants, while the accumulation of
the proteasome-sensitive transcription factor EIN3 (51) demon-
strated the efficiency of the chemical (SI Appendix, Fig. S5 C,
Top). Note that AGO1 transcript level was increased following P0
induction, ruling out, again, any negative effect on transcription to
explain AGO1 decay (SI Appendix, Fig. S5 C, Bottom). From these
experiments, we conclude that P0 can bypass autophagy deficiency
to achieve a reduction in AGO1 protein level even when its de-
livery to the vacuole appears to rely on canonical autophagy.
P0 Is Engulfed by ATI1- and ATI2-Decorated Bodies on the ER and Is
Delivered with Them to the Vacuole. To get insight into the P0 ER-
to-vacuole delivery pathway, we decided to examine the possible
involvement of the ER and autophagy-associated ATI1/2. We
were particularly intrigued by the morphological resemblance (as
seen in bright-field imaging) of the P0- and AGO1-containing
bodies in the vacuole (SI Appendix, Fig. S6A) and cytosol (SI
Appendix, Fig. S6B), with the ER-associated and ATI1-decorated
bodies (ATI-bodies) reported earlier (42). ATI1/2 were shown to
interact with ATG8 proteins and to be delivered on dynamic ER-
derived ATI-bodies to the vacuole (42). To examine the possible
involvement of ATI1/2 in the process of P0-mediated AGO1































decay, we first expressed ATI1-mCherry or ATI2-mCherry with
P0-GFP in N. benthamiana leaf epidermal cells. Already at 30 hfa,
we could detect the P0-GFP signal colocalizing with ATI1-
mCherry labeled bodies (Fig. 3 A, Top) in a manner similar to
P0 colocalization with ATG8a (Fig. 2A). Notably, at 120 hfa, the
P0-GFP signal was detected engulfed by a ring-shaped ATI1-
mCherry signal (Fig. 3 A, Middle), and, occasionally, structures
reaching the size of 5 μm in diameter (Fig. 3 A, Bottom) were
detected. Similar results were obtained when ATI2-mCherry was
expressed with P0-GFP (SI Appendix, Fig. S7A). Moreover, we
could also detect bodies within the vacuole lumen displaying both
ATI1 and P0 signals in both epidermal (SI Appendix, Fig. S7B)
and mesophyll cells (SI Appendix, Fig. S7C).
Next, we transformed Arabidopsis plants harboring ATI1-
GFP under the regulation of the ATI1 endogenous pro-
moter [pATI1:ATI1-GFP (43)] with the XVE:P0-mRFP construct.
Seedlings containing both markers were imaged following 18 h of
treatment with β-Es and ConcA. Their vacuoles exhibited a large
number of bodies, many of which appeared to be labeled with
both P0-mRFP and ATI1-GFP proteins (Fig. 3B). Quantification
of the relative abundance of each of the body types within vac-
uoles of P0-mRFP−expressing cells revealed that 80.5% of these
bodies contained both proteins (yellow bar), 17% contained only
ATI1-GFP (green bar), and 2.5% contained only P0-mRFP (red
bar) (Fig. 3C). This indicates that the majority of the P0 cargo is
delivered to the vacuole via ATI-bodies.
Fig. 2. Effects of autophagy deficiency on P0 flux to the vacuole and AGO1 degradation. (A) CLSM imaging of a tobacco leaf epidermal cell, transiently
expressing P0-GFP (P0) and mRFP-ATG8a (ATG8a). A representative body that contains both P0 and ATG8a is designated as autophagosome (Aut). The nucleus
(Nuc) and cytoplasm (Cyt) are marked as well. (B) CLSM imaging of cells in the (Left) root elongation zone and (Right) meristematic zone from Arabidopsis
lines harboring XVE:P0-mRFP in the background of Col-0, atg5-1, and atg7-2, following treatment with β-Es and ConcA. Vacuole lumen (Vac) is indicated as
well as large (∼5 μm in diameter) cytosolic structures (arrowheads). (C) Quantification of the amount of P0-mRFP labeled autophagic bodies normalized to
1,000 μm2 of vacuole lumen focal plane, in the background of the indicated genotypes. Plants were chosen for quantification based on their comparable P0-
mRFP fluorescence intensity as detected from their cell’s cytosol. Values represent mean ± SEM (n = 21, 30, and 23 elongation zone cells for Col-0, atg5, and
atg7 backgrounds, respectively); * denotes statistical significance of mutants compared to wild type, P < 0.01 (t test). (D) (Top) Immunoblot analysis of total
proteins from XVE:P0-myc containing lines in the background of Col-0, atg7-2, atg5-1, and ago1.57 seedlings that were germinated on 0, 10, or 20 μM of β-Es.
Blots were probed with specific antibodies as indicated, and CB staining serves as loading control. (Bottom) Samples indicated in Top were also analyzed for
AGO1 and P0 transcript levels by qRT-PCR. Values are average ± SD relative to P0-myc without β-Es.






















P0 Induces the Flux of ATI-Bodies to the Vacuole. The accumulation
of P0- and ATI1-labeled autophagic bodies in vacuoles suggests
that P0 may induce an ER-derived degradation pathway in-
volving ATI1. To investigate this possibility, we examined the
response of the pATI1:ATI1-GFP/XVE:P0-mRFP transgenic
line and its corresponding parental line that does not contain P0-
mRFP (pATI1:ATI1-GFP) to β-Es and ConcA treatment. We
reasoned that any change in the flux of ATI1-GFP bodies to the
vacuole could be attributed solely to P0-mRFP expression. Con-
focal imaging revealed that, although there was a basal flux of
ATI1-GFP bodies to the vacuoles in the parental line, there were
significantly more bodies in the vacuoles of the plants expressing
P0-RFP (Fig. 4A). Indeed, further quantification revealed a 5-fold
increase in the number of vacuolar ATI1-GFP bodies in plants in
which P0-RFP has been induced (Fig. 4B). Strikingly, this induction
of ATI1-bodies was not accompanied by increased transcript nor
protein levels of ATI1-GFP (Fig. 4C) as inferred from the exam-
ination of pATI1:ATI1-GFP/XVE:P0-mRFP and pATI1:ATI1-GFP
seedlings grown on mock (DMSO) or 5, 10, and 20 μM β-Es. To
investigate whether P0 induction might show a broader effect
on the transcript levels of autophagy-related genes, we ana-
lyzed the transcript level of ATI1, ATI2, ATG8a, NBR1, ATG5,
ATG2, and ATG7 in mock or 10 μM β–E−treated Col-0 or
XVE:P0-myc plants. Despite a strong induction of P0-myc
expression in the β–E−treated XVE:P0-myc plants, there was
no significant change in the transcript of any of the tested genes
(Fig. 4D). Together, these results suggest a posttranslational
effect driven by P0 for the induction of the ATI degradation
pathway.
ATI1 Interacts with AGO1 on the ER, and ATI1/2 Deficiency
Compromises Posttranscriptional Gene Silencing. Our results sug-
gest that P0 induces the ATI degradation pathway, which may
represent an endogenous pathway for the turnover of ER-
bound AGO1. Therefore, we wondered whether ATI1/2 are
involved in AGO1 regulation independently of P0. First, we
expressed ATI1 fused to mCherry (ATI1-mCherry) with GFP-
AGO1 transiently in N. benthamiana leaves to examine whether
AGO1 and ATI1 are associated. Both proteins colocalized on
the ER and also in ER-associated bodies, wherein ATI1 engulfed
the GFP-AGO1 signal, forming a ring-like shape (Fig. 5A). As the
ATI pathway is induced by starvation (42), we examined ATI1-
GFP or GFP-AGO1 degradation kinetics in response to carbon
and nitrogen deficiency (−C−N) by assessing the ratio of full-
length proteins with free-GFP degradation products. Notably,
the 2 proteins behaved similarly, where, at 24 h, degradation was
initiated and subsequently increased following the onset of star-
vation (SI Appendix, Fig. S8 A and B). Yet comparing GFP-AGO1
starvation-mediated degradation with P0-induced degradation
revealed a greater effect of starvation (SI Appendix, Fig. S8C).
To evaluate ATI1 and AGO1 mutual dynamics during star-
vation, we generated transgenic lines harboring pAGO1:GFP-
AGO1 and XVE:ATI1-mCherry in the ago1-27 background.
We then applied β-Es to induce ATI1- or ATI2-mCherry
Fig. 3. ATI1 engulfs P0 on the ER, and both proteins are delivered to the vacuole. (A) N. benthamiana epidermal leaf cells transiently expressing P0-GFP and
ATI1-mCherry were imaged by CLSM at (Top) 30 and (Middle and Bottom) 120 hfa. Arrowheads designate structures containing P0-GFP and surrounded by
ATI1-mCherry ring-like shapes. White arrow marks a large (∼5 μm in diameter) body. BF, bright field. (B) Cells in the root elongation zone of Arabidopsis
seedlings harboring pATI1:ATI1-GFP and XVE:P0-mRFP, imaged following treatment with β-Es + ConcA. (C) Quantification of the relative number of bodies
exhibiting only ATI1-GFP (green), only P0-mRFP (red), or both ATI1-GFP and P0-mRFP double labeling (yellow) out of the total number of bodies inside
vacuoles. Values represent ratio means minus SEM (n = 12 plants) of data collected from a total of 51 cells in the elongation zone and normalized to 1,000 μm2
of vacuole lumen focal plane.































expression along with 24 h of darkness and 16 h of ConcA
treatment. Confocal Laser Scanning Microscopy (CLSM) im-
aging of cells in the elongation zone revealed the accumulation
of bodies within the vacuole lumen, most of which harbor both
GFP-AGO1 and ATI1-mCherry (Fig. 5B), reminiscent of the
colocalization of ATI1-GFP and P0-mRFP in the vacuole (Fig.
3B). Note that arrowheads in Fig. 5 B, Inset highlight ring-like
shapes of ATI1-mCherry signal engulfing GFP-AGO1 signal, a
morphology that is preserved up to the vacuole.
These observations prompted us to examine whether ATI1/2
could directly interact with AGO1. We first used a yeast 2-hybrid
approach. Due to problems of expression of the full-length AGO1
protein in this system, we examined separately the AGO1
N-terminal half extending from the PolyQ to the PAZ domain
and the C-terminal half (L2-Ct) (Fig. 5C). In this system, AGO1
interacted with ATI1 and ATI2, although less strongly than with
ATG8a used here as a control (Fig. 5C). This was especially
evident for the interaction of ATI1 with the AGO1 PolyQ-PAZ
N-terminal half. To validate the interactions in planta, we also
performed Bimolecular Fluorescence Complementation (BiFC)
assays (SI Appendix, Fig. S9). Thus, we generated BiFC construct
combinations and tested them in agroinfiltrated tobacco leaves.
We found that AGO1 interacted with ATI1 in cellular structures
exhibiting an expression pattern that resembles the pattern
generated by the combination of ATI1 and ATG8a. However,
AGO1 combined with the empty vectors or with ATG8a did not
produce such fluorescence (SI Appendix, Fig. S9A). Next, N.
benthamiana infiltrated leaf patches were further treated with
ConcA in the dark for 16 h. Under these condition, bodies
emitting YFP fluorescence within vacuoles were detected when
ATI1 was combined with AGO1 or ATG8a (SI Appendix, Fig.
S9B, white arrowheads), but not when coexpressed with
FBW2, an F-box protein that was previously suggested to be
associated with AGO1 (52). This confirms that ATI1−AGO1
interaction is preserved up to the vacuole (SI Appendix, Fig.
S9B). To evaluate whether this association is detected also in
Arabidopsis, we further performed coimmunoprecipitation (Co-
IP) assays of AGO1 from 35S:ATI1-GFP expressing plants. As
control, we used the Arabidopsis pKAO2:KAO2-GFP line express-
ing an ER-associated ent-kaurenoic acid oxidase 2 (KAO2),
a gibberellin biosynthesis enzyme fused to GFP (53), show-
ing an expression level comparable to ATI1-GFP. Indeed,
Fig. 4. P0 induces ATI1-labeled bodies flux to the vacuole without affecting ATI1 protein or transcript levels. (A) Cells in the root elongation zone of seedlings
harboring pATI1:ATI1-GFP alone or pATI1:ATI1-GFP with XVE:P0-mRFP were treated with β-Es + ConcA for 16 h before vacuole focal planes were imaged with a
CLSM. (B) Quantification of ATI1-GFP-labeled bodies per vacuole lumen area unit (750 μm2) from pATI1:ATI1-GFP (−P0) or pATI1:ATI1-GFP/XVE:P0-mRFP (+P0).
Values represent means ± SEM (n > 30). Statistical significance (*P < 0.001) was revealed by Student’s t test. (C) Immunoblot analysis of total proteins from
pATI1:ATI1-GFP alone or pATI1:ATI1-GFP/XVE:P0-mRFP seedlings germinated on 0 (DMSO), 5, 10, and 20 μM β-Es for 6 d. (Top) Blots were probed with specific
antibodies as indicated (Upper). CB staining serves as loading control. (Bottom) Samples indicated in Top were also analyzed for AGO1 and ATI1-GFP transcript
levels by qRT-PCR. Values are average ± SD relative to pATI1:ATI1-GFP without β-Es. (D) Relative transcript levels of selected autophagy-related genes
(indicated) in Col-0 and XVE:P0-myc seedlings treated with either mock (DMSO) or 10 μM β-Es. Values are average ± SD relative to the corresponding
gene expression in Col-0 treated with DMSO.






















immunoprecipitation of AGO1 coprecipitated ATI1-GFP, but
not KAO2-GFP (Fig. 5D).
We consequently examined the steady-state level of AGO1
protein in ATI1/2-deficient plants. The already reported SAIL_
404_D09 line (ati1) was used, either as a single mutant or
combined with an RNAi construct that reduces ATI2 expression
by 80% (42) (SI Appendix, Fig. S10A), which we termed ati1ati2KD.
In addition, we applied the CRISPR-Cas9 approach to target
ATI2 in the background of the ati1 mutant line. This yielded a
5-base pair (bp) deletion in ATI2 that resulted in a frameshift
generating an early stop codon after the new codon number 88
(SI Appendix, Fig. S10B). This double mutant was named
ati1ati2STOP. Similar to ati1ati2KD, the ati1ati2STOP mutant was
viable and did not exhibit visible developmental alterations
in our growing conditions (SI Appendix, Fig. S10C). In all ati1/2
mutants, as well as in atg5-1, we observed a mild increase in
Fig. 5. ATI1 associates with AGO1 on the ER and in the vacuole independently of P0, and ATI1/2 are required for S-PTGS. (A) (Left) CLSM imaging of a tobacco leaf
epidermal cell transiently expressing GFP-AGO1 and ATI1-mCherry. (Right) A magnification of the area indicated by a dashed line in Left. The arrowhead highlights
a representative spherical structure labeledwith ATI1-mCherry and enriched with GFP-AGO1 signal. (B) Transgenic ago1-27 seedlings expressing pAGO1:GFP-AGO1
and XVE:ATI1-mCherry were treated with both β-Es and ConcA, and the vacuolar focal plane of cells in the root elongation zone was imaged by a CLSM.
Magnification of the area indicated by a dashed line is presented, with arrowheads highlighting spherical structures exhibiting ATI1-mCherry engulfing GFP-AGO1
signal. (C) Y2H-assay for interaction analysis of ATI1 or ATI2 with either the N-terminal (PolyQ-PAZ) or C-terminal (L2-Ct) halves of AGO1. (Top) A scheme illus-
trating the PolyQ-PAZ (N-terminal) and L2-Ct (C-terminal) fragments of AGO1 and their amino acid coordinates. (Bottom) Yeast cells expressing ATI1 or ATI2 as AD
fusion and PolyQ-PAZ or L2-Ct as BD fusion show growth on selective medium, without leucine and tryptophan (−LW) or leucine, tryptophan, and histidine
(−LWH). Combinations with empty BD or AD vectors (−) are also shown. Interactions of ATI1 or ATI2 with ATG8a serve as a positive control. Yeast cells representing
all combinations were plated directly or following 10- or 100-fold dilutions. (D) Co-IP analysis of AGO1 from crude protein extracts of 35S:ATI1-GFP or
pKAO2:KAO2-GFP plants, performed with beads conjugated to @AGO1 antibodies. Input and IP fractions were immunoblotted with @AGO1 and @GFP (JL8)
antibodies. (E) S-PTGS efficiency in the indicated genotypes. GUS activity was measured in leaves of 50-d-old plants. For each genotype, 96 plants were analyzed.
S-PTGS efficiency is expressed as the percentage of GUS-negative plants. (F) Immunoblot analysis of total protein from 10-d-old XVE:P0-myc and XVE:P0-myc/
ati1ati2KD seedlings grown onMS plate, then treated as indicated. For treatment, the seedlings were transferred to liquid MS containing DMSO (Mock treatment),
β-Es (10 μM), MLN4924 (25 μM), or ConcA (1 μM) in the indicated combinations and left in the growth chamber with mild steering for 24 h. Blots were probed with
antibodies raised againstArabidopsis AGO1 and the c-MYC tag. CB staining serves as loading control. (G) Immunoblot analysis of total, microsomal pellet (Micros.),
and supernatant (Soluble) protein preparations from XVE:P0-myc and XVE:P0-myc/ati1ati2KD 6-d-old seedlings grown on MS plates, then treated as indicated; 1/2
MS liquid media containing either DMSO (−) or 20 μM β-Es (+) was added directly on vertically growing seedlings for 24 h before protein extraction. Blots were
probed with antibodies raised against Arabidopsis AGO1, the c-MYC tag (top membrane), luminal binding proteins BiP1/BiP2/BiP3 (BiP), and UGPase (bottom
membrane). CB staining on both membranes serves as loading control.































AGO1 protein steady-state levels as compared to Col-0 (SI Ap-
pendix, Fig. S10D).
Finally, we investigated whether ATI1/2 loss of function affects
AGO1-based silencing activity. For this purpose, we used the
Hc1 silencing reporter line (54) that triggers AGO1-dependent
S-PTGS in only 20% of the population at each generation (54)
and thus represents an excellent sensor to precisely monitor
changes in silencing efficiency (55). In particular, it was shown
previously that expressing an miR168-resistant form of the
AGO1 mRNA in this line increases S-PTGS efficiency up to
100%, indicating that the amount of AGO1 protein available for
S-PTGS is limiting in wild-type plants (56). While, as expected,
about 20% of silencing was observed in the Col-0 background,
100% of the Hc1/ati1ati2STOP plants were silenced (Fig. 5E),
similar to the Hc1/4mAGO1 plants that were used as a control.
From these results, we conclude that, while ATI1/2 deficiency
has only a minor effect on total AGO1 steady-state protein level,
it significantly enhances S-PTGS, likely by increasing the avail-
ability of AGO1 for S-PTGS.
ATI1/2 Deficiency Attenuates P0-Mediated Decay of Membrane-
Associated AGO1. Next, we investigated whether P0-mediated
AGO1 protein degradation is affected in ATI1/2-deficient plants.
Thus, the XVE:P0-myc line was crossed with the ati1ati2KD
mutant line. Interestingly, when we induced P0-myc expression
for a short period (treating seedlings with β-Es or mock for 24 h),
AGO1 degradation was attenuated in the ati1ati2KD mutant
background, despite a higher expression level of P0-myc (Fig.
5F). To get further insight into this process, we performed mi-
crosomal preparations from XVE:P0-myc seedlings in Col-0 and
ati1ati2KD backgrounds that were subjected, or not, to 24 h of β-Es
to induce P0-myc. Western-blot with anti-AGO1 antibodies
revealed decreased AGO1 level in the total protein fraction in
the Col-0 background relative to the ati1/2 mutant background
(Fig. 5G). As most AGO1 protein was found in the microsomal
fraction, its impaired degradation in this fraction suggests that
ATI1/2 are required especially for membrane-bound AGO1
degradation via P0. However, this effect was not observed when
seedlings were treated with β-Es or mock for 7 d after their ger-
mination (SI Appendix, Fig. S11), indicating that long-term
induction leading to higher level of P0 expression is able to
overcome the absence of ATI1/2 and likely proceed with AGO1
degradation through an unrelated degradation pathway.
Discussion
The Route for P0-Mediated ER-To-Vacuole Delivery of AGO1. Several
studies in different organisms and cell types indicate that AGO
proteins display multiple intracellular localizations (reviewed in
refs. 57 and 58). Thus, AGOs could be detected as soluble
proteins in the cytosol and nucleus, as part of a dense complex of
macromolecules termed P-bodies, in foci termed siRNA-bodies
or stress granules, and, at least, human AGO2 was also reported
to be associated with multivesicular bodies (MVBs) and even
mitochondria. In plants, reporter lines expressing functional
GFP-AGO1 argue for cytosolic distribution for most of the
protein, at least in root cells (29, 59). Nonetheless, a significant
pool of AGO1 protein was found membrane-bound (13, 47),
where the RISC appears to exert its translation repression ac-
tivity. Intriguingly, miRNA RISCs are not only present in
membrane-bound polysomes, but they can trigger there sec-
ondary siRNA production from both coding and noncoding
RNA (48). These results suggest that both the translation re-
pression and the endonuclease functions of AGO1 may occur on
the ER. This is not unique to plants, as translation repression by
a special type of ER-associated RISC was also reported in
Drosophila cells, especially following starvation (60), and the
outer rough ER membrane was suggested as the site of human
Ago2 loading with siRNA and of mRNA slicing (61). Our live-
cell imaging and immuno-EM approaches further support the ER
localization of AGO1, although it might also localize to other
membranes such as the plasma membrane. Notably, treatment
with β-Es and ConcA resulted in a significant enrichment of
AGO1 along the ER. As ConcA inhibits cellular trafficking and
autophagy, it is likely that the ER represents the major site from
which AGO1 is sent to the vacuole for degradation under normal
growing conditions.
This strong enrichment of AGO1 on the ER raises the ques-
tion of where, at the subcellular level, does P0 encounter AGO1
to trigger its degradation. The nucleus would have been a site of
choice, as numerous F-box proteins target their substrates in this
compartment (62). Moreover, AGO1 loading by at least miRNAs
is likely to be nuclear (59). Therefore, AGO1 conformational
changes in this compartment might favor the recognition of its P0
degron (46). In addition, autophagy-mediated degradation of
Arabidopsis nuclear-localized proteins and even protein complexes
was already demonstrated (41, 63). However, our data point to the
ER as the main site where P0 interacts with AGO1. Likely, P0
interacting with AGO1 on the ER induces a flux of bodies con-
taining both the F-box and its target, which are subsequently de-
graded in the vacuole (Fig. 1F). Interestingly, these bodies
resembled ATI1/2 spherical bodies that were shown to be involved
in direct ER-to-vacuole trafficking under carbon starvation (42).
ATI1/2 Deficiency Displays a Mild Effect on Total AGO1 Protein Level,
yet a Significant Effect on Its Function. ATI1/2 were previously
detected localized in ER membranes and in dark-induced ER-
associated bodies that eventually reach the vacuole (42). Nev-
ertheless, the identities of potential ER-localized cargos carried
via the ATI1/2 pathway were so far unknown. If AGO1 would be
a cargo of this pathway, one could hypothesize that the loss of
ATI1/2 function may affect AGO1 stability or activity. Regarding
its stability, the analysis of single and double ati1/2 mutants
showed no major increase of AGO1 protein steady-state level in
total extracts when compared to Col-0 (SI Appendix, Fig. S10D).
Also, similarly to atg5 and atg7, the ati1/2 mutant did not prevent
AGO1 degradation following long and constitutive expression of
P0 (SI Appendix, Fig. S11 and Fig. 2D). However, ATI1/2 de-
ficiency led to increased stability of AGO1 when P0 was induced
for a relatively short duration, an effect that was prominent in
microsomal preparations (Fig. 5 F and G). This may be the result
of a more profound effect of P0 on the ER in initial time points,
whereas, during long overexpression, P0 may exert its function in
other subcellular locations of AGO1, in which ATI1/2 might not
be involved. Note that AGO1 protein accumulation in ati1/2,
atg5, and atg7 mutant backgrounds might be attenuated by
miR168-dependent feedback loop regulating AGO1 expression
(64), and possibly also by an alternative route for AGO1 decay
(discussed below). Another possible explanation for the mild
effect of ATI1/2 on AGO1 level is the existence of additional, yet
unknown, autophagy receptors that target AGO1 or other RISC
components that might function cooperatively with ATI1/2 for
AGO1 degradation. This idea gains support from a recent
study that compared the function of mammalian ER-phagy
receptors (65). This work revealed that deficiency in 4 out of 5
known ER-phagy receptors did not fully abolish ER-phagy ac-
tivity and that the 3 major receptors (TEX264, CCPG1, and
FAM134B) act cooperatively to execute ER-phagy. Therefore
ATI1/2 may serve as ER-phagy receptors whose function is in-
duced upon P0 expression to carry ER fragments to the vacuole
along with associated molecules. Interestingly, ATI1/2 were re-
cently reported to interact with ATG8 via their intrinsically
disordered regions that harbor the ATG8-Interacting Motif do-
mains (66), a feature that seems to be common among ER-phagy
receptors (65). Yet, even under such a scenario, some degree
of specificity toward AGO1 is certain, as demonstrated by






















ATI1−AGO1 binding and their codelivery to the vacuole while
remaining bound (Fig. 5 C and D and SI Appendix, Fig. S9).
Finally, the significant effect of ATI1/2 deficiency on AGO1
function further supports the role of this pathway in selective
targeting of AGO1. Thus, the ati1ati2STOP mutant increased sig-
nificantly S-PTGS efficiency of theHc1 line, indicating that ATI1/2
limits S-PTGS efficiency. Because AGO1 is a limiting factor for
PTGS (56), we speculate that the lack of ATI1/2 might increase
AGO1 activity at specific locations (e.g., the ER) that subsequently
could increase S-PTGS efficiency.
Does the Loading of AGO1 by sRNAs Affect the Degradation by P0? It
has previously been proposed that P0 triggers the clearance of
unloaded AGO1 (24). However, this does not seem consistent
with the association of P0 with the ER-localized pool of AGO1,
presumably in an active and loaded form. This is further sup-
ported by the facts that 1) P0 reduces the amount of miRNAs
and siRNAs in microsomal fractions (SI Appendix, Fig. S1) and
2) P0 induces the ER-derived ATI pathway, which apparently
limits S-PTGS activity. The discrepancy between our observa-
tions and the report of Csorba et al. (24) may be explained by the
fact that their experiments were conducted with transient over-
expression assays. This approach may result in the disruption of
the balance between the nuclear and cytosolic pools of AGO1
(59). That being said, the efficiency of P0 in degrading AGO1
and other AGO proteins suggests that P0 could function in
several compartments and probably on several forms of AGO1.
This idea gains support from the observation that AGO1 is ef-
ficiently degraded in both the microsomal and soluble fractions
and that AGO4, which is exclusively soluble (48) and mainly
localized in the nucleus, is efficiently degraded by P0 (Fig. 1A).
Autophagy Is Not the Only Pathway for P0-Mediated AGO1 Decay.
One unexpected and intriguing observation of our work is the
inability of autophagy deficiency to block P0-mediated degra-
dation of AGO1 (Fig. 2D), especially because general inhibitors
that interfere with trafficking pathways and block vacuolar deg-
radation prevented the AGO1 decay pathway (29). Moreover,
while P0-mediated degradation of membranous AGO1 was at-
tenuated in the ati1ati2KD mutant (Fig. 5 F and G), long-term
induction of P0 still led to AGO1 protein decay (SI Appendix,
Fig. S11). Therefore, it is possible that P0 channels AGO1 for
degradation via autophagy as well as via an autophagy-independent
pathway, either generally or specifically when autophagy is
blocked. It is known that cargos are sent to the vacuole also via
MVBs (67, 68); however, no significant association with MVBs
was previously observed for GFP-AGO1 (29). Notably, alternative
routes of autophagy, such as Atg5/Atg7-independent macro-
autophagy, have been reported in mammals (69), but their func-
tion and mechanisms are still not well understood.
The human Ago2 protein can be degraded in a proteasome-
dependent manner (70). Alternatively, human Ago2 was also
been found associated with the nuclear dot protein 52 (NDP52),
which is a cargo receptor for autophagy (71). We therefore in-
vestigated whether the 26S proteasome may mediate AGO1
decay if autophagy was impaired, but this was also not the case
(SI Appendix, Fig. S5C). However, as a functional F-box domain
is essential for the assembly of SCFP0, its interaction with AGO1
and its subsequent degradation (46), it is likely that the ubiq-
uitylation of AGO1 or a protein associated with AGO1 triggers
these degradation pathways. Therefore, we conclude that con-
ventional autophagy is not the only route for P0-mediated AGO1
degradation in plant cells and further research is required to
reveal additional pathways.
Proviral and Antiviral Functions of Autophagy. The pivotal role of
autophagy during viral infection in plants has only recently
emerged with reports demonstrating both antiviral and proviral
functions (44, 45). Thus, in Arabidopsis, the autophagy receptor
NBR1 was shown to limit cauliflower mosaic virus infection via
targeting of viral capsid proteins and particles for degradation
(39). Similarly, ATG8F from tobacco and tomato interacts with
the virulence factor βC1 of Cotton leaf curl Multan virus (72)
and tobacco Beclin1 interacts with turnip mosaic virus (TuMV)
RNA-dependent RNA polymerase (73), leading to the degra-
dation of the viral proteins via autophagy and thus limiting the
corresponding viral infections. In contrast to these antiviral func-
tions, viruses also manipulate autophagy for their benefits. Thus,
TuMV can suppress NBR1-mediated selective autophagy of the
VSR HcPro (74), whereas VPg, a VSR from the same virus, was
shown to induce both autophagy and proteasomal degradation of
the host antiviral silencing component, SGS3 (75). Most of these
reports also demonstrated that viral infections were accompanied
by autophagy induction. This was shown by the elevation of
both the protein and transcript levels of ATG genes, as well as
the accumulation of ATG8-labeled structures (39, 72, 75). However,
viral components inducing autophagy are not well known.
Here we show that a single viral protein is sufficient to induce
a specialized degradation pathway that originates from the ER.
Notably, P0 did not result in the elevation of ATI1-GFP protein
or gene expression (Fig. 4C), nor did it result in the increased ex-
pression of other autophagy-related genes (Fig. 4D). Hence, while
autophagy induction may represent a global response to viral in-
fection, some viral proteins may act in a more specialized manner to
induce specific degradation pathways, likely for the benefit of the
infection. Therefore, it is possible that, by merely the physical as-
sociation of P0 with AGO1, the autophagy machinery is recruited
to their interaction sites and delivers both proteins to the vacuole.
According to such a scenario, P0 would act as a suicidal protein
that is sacrificed by the virus to eliminate antiviral AGO proteins.
Materials and Methods
Plant Material, Growth Conditions, and Treatments with Chemicals. Arabi-
dopsis ecotype Colombia as well as N. benthamiana (for transient ex-
pressions) were used in this study. Arabidopsis mutants atg5-1, atg7-2,
ati1ati2KD, and ago1-57 (38, 42, 46) and the pAGO1:GFP-AGO1/ago1.27
(29), 35S:ATI1-GFP (42), pATI1:ATI1-GFP (43), and pKAO2:KAO2-GFP (53)
transgenic lines were previously described. For P0 expression, β-Es–responsive
transgenic lines were obtained following floral dipping of Col-0, atg5-1, atg7-2,
and pATI1:ATI1-GFP with Agrobacterium tumefaciens harboring XVE:P0-mRFP.
The pAGO1:GFP-AGO1/ago1-27was floral-dipped with agrobacteria harboring
XVE:P0-mRFP or XVE:ATI1-mCherry. Different genotypes were crossed to
generate atg7-2/XVE:P0-myc and atg5-1/XVE:P0-myc. The list of primers
used for genotyping is presented in Dataset S1.
The Arabidopsis ati1ati2STOP mutant line was generated by floral-dipping−
mediated transformation (Agrobacterium strain GV3101 pMP90) of ati1 (SAIL_
404_D09) mutant plants with the CRISPR construct described below. Hygromycin-
resistant plants were sequenced, and one plant containing a 5-bp deletion in the
ATI2 gene sequence was chosen. Cas9-free (hygromycin sensitive) plants were
then selected from a T3 population and confirmed by PCR and sequencing using
primer ATI2Crisp_F and ATI2Crispr_R (Dataset S1) and used for further analysis.
For β-Es−mediated protein induction and chemical treatments, seeds
were germinated on solid half-strength MS (pH 5.8) containing 1% sucrose
(0.5 MS/suc) within 6-well plates that were positioned vertically. Five days
following transfer to the growth room, 1 mL of liquid 0.5 MS/suc containing
the indicated β-Es concentrations, with or without ConcA (1 μM), was applied
in each well before imaging or protein/RNA extractions were conducted.
Similar treatments with the appropriate amount of DMSO served as mock.
Alternatively, seedlings were grown on horizontal MS containing 1% sucrose
and then transferred to liquid MS medium containing the indicated drugs
(β-Es, MLN4924, ConcA) for the indicated duration. For long-term induction,
seedlings were germinated on solid half-strength MS media containing β-Es at
the indicated concentrations (2, 5, 10, or 20 μM). Dark-induced starvation was
applied as previously described (43). Unless otherwise specified, plants were
grown under a 16 h light/8 h dark diurnal regime (long day). Chemicals are
listed in Dataset S2.
Plasmid Construction. To generate XVE:ATI1-mCherry, the ATI1-mCherry coding
sequence was amplified from established plasmids (42, 43) with flanking attB































sites (Dataset S1) and introduced into the pDON221 Vector (ThermoFisher).
Note that the ATI1 coding sequence (CDS) contains a T348C silent mutation.
Then, the gateway system was used to introduce the fused genes to
pMDC7 vectors already harboring the β-Es−inducible system (76).
To generate 35S:GFP-AGO1, AGO1 CDS was amplified using primer
attB1_AGO1_ F and attB2_AGO1_R (Dataset S1) and first mobilized into
pDNR221. Then a second recombination using LRclonaseII was used to
transfer AGO1 CDS into pB7WGF2.
To generate the pGADT7-ATI1, pGADT7-ATI2, and pGBKT7-ATG8a for
expression in yeast, the coding sequences of all 3 proteins were first amplified
from previously described plasmids (29, 42, 43) from ATG to stop codon
(Dataset S1) and mobilized into the pDONR/Zeo Vector (ThermoFisher) via
BPclonase II reaction. N-terminal and C-terminal parts of AGO1, respectively
called polyQ-PAZ (Met1 to Glu501 of AGO1 CDS) and L2-Ct (Gly502 to Cys1048
of AGO1 CDS), were amplified using primers attB1_PolyQ-PAZ(AGO1)_F/attB2_
PolyQ-PAZ(AGO1)_R and attB1_L2-Ct(AGO1)_F/attB2_L2-Ct(AGO1)_R (Data-
set S1) and mobilized into pDONR/Zeo Vector using BP clonase II reaction.
Then, the gateway system was used to introduce the different sequences
into either the pGADT7-GW (AD) or the pGBKT7-GW (BD) destination
vectors via LRclonase II reaction.
P0 and P0LP were cloned from existing P0 clones into the pENTRY vector
with attB sites (Dataset S1) and further mobilized using the GatewayTM technology
into pH7RWG2, pK7FWG2, and pER8GWR to generate 35S:P0-mRFP, 35S:P0-
GFP, and XVE:P0-mRFP and XVE:P0LP-mRFP, respectively. The pER8GWR was
generated by introducing the ccdB-RFP cassette from pH7RWG2.0 (SacII-SpeI
fragment treated with mung bean nuclease followed by a treatment with
DNA polymerase Klenow fragment) into the XhoI site of the pER8 vector (76)
treated with the DNA polymerase Klenow fragment.
The CRISPR construct was built using the GoldenBraid cloning system (77)
in pCAMBIA binary vectors. The Cas9 construct had been codon-optimized for
expression in Arabidopsis plants under the regulation of a UBI10 promoter
(78). Target-binding sequences were cloned into the BbsI sites of the U6-
26:gRNA pGREEN vector as a T4 Polynucleotide Kinase-treated comple-
mentary-annealed oligonucleotide. For primers, see Dataset S1.
For BiFC assay-related plasmids, pENTRY clones harboring the CDS of ATI1,
ATG8a, AGO1, and FBW2 were recombined to BiFC-compatible destination
vectors pYFPN43 or pYFPC43 using the Gateway recombination cloning system.
For primers, see Dataset S1.
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